The association between dehydroepiandosterone and frailty in older men and women.
about
Biomarkers for physical frailty and sarcopenia: state of the science and future developmentsMeasures of frailty in population-based studies: an overviewThe implication of frailty on preoperative risk assessmentFrailty in elderly peopleEffect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review.Low Levels of Dehydroepiandrosterone Sulfate in Younger Burnout Patients.Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilizationNon-androgenic Anabolic Hormones Predict Risk Of Frailty: European Male Ageing Study Prospective Data.Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older peopleInflammatory markers and incident frailty in men and women: the English Longitudinal Study of Ageing.The frailty syndrome: a comprehensive review.Hypothalamic-pituitary-adrenal (HPA) axis and aging.Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment.Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.Mathematical modelling of decline in follicle pool during female reproductive ageing.Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women.Low free testosterone is associated with loss of appendicular muscle mass in Japanese community-dwelling women.Dehydroepiandrosterone sulfate levels in Turkish obese patients.Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study.The concept of multiple hormonal dysregulation.Frailty assessment in older adults with chronic obstructive respiratory diseases
P2860
Q26775328-D9327228-6A24-4021-961A-D44B52E42A8DQ27027509-633B7FDB-75B4-4DAE-8DE0-D0C43E5128C7Q33825857-5D9C46ED-5707-44C9-877F-BB5126F9E916Q33902569-758442E3-F4C7-46ED-AC23-8554E98E1155Q34190476-1C9C85D8-F12A-49A2-BF11-C87EEFD81F76Q36126889-A8C16820-70F4-42BC-8961-6A55E6898593Q36165407-C878CACF-F821-421B-A4D3-C2CDD8BCC4D7Q36400630-DAB35DAF-4B83-44F7-A34F-E13A301A2A88Q36795176-C3296D9F-6463-416D-A637-FFDA999A1541Q37116540-05449B47-C2CB-463A-B69D-55666B680812Q37958026-6BD38EDB-6372-4C38-8597-7AECC71B2868Q38271908-CF73F1D5-C51E-48D7-BB67-6E38206FF16AQ38345471-BDCB4106-AE7C-4DF3-B15F-30E7B0D14982Q38404732-E0222822-9117-4CAF-8632-D678111FA075Q41183653-B3DAE642-F449-4F6B-B36D-019DAA3DFD21Q42878364-A29B258F-2221-46AD-B8F2-6DA1737E3CA6Q43778079-F6AAD158-81F0-437A-A195-FE774E1CBA1DQ51147705-88506D6F-BA41-4CA9-8E06-555DA9599557Q51373317-A039ECF1-45A3-4F03-BDB8-1A1B2ABD3A1AQ54867290-48A29A8E-2ADB-4CCF-A6EA-8C37BDF988F9Q58694396-AA2862DC-239E-4DBD-AC18-62BE9B703C07
P2860
The association between dehydroepiandosterone and frailty in older men and women.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The association between dehydroepiandosterone and frailty in older men and women.
@en
The association between dehydroepiandosterone and frailty in older men and women.
@nl
type
label
The association between dehydroepiandosterone and frailty in older men and women.
@en
The association between dehydroepiandosterone and frailty in older men and women.
@nl
prefLabel
The association between dehydroepiandosterone and frailty in older men and women.
@en
The association between dehydroepiandosterone and frailty in older men and women.
@nl
P2093
P2860
P356
P1433
P1476
The association between dehydroepiandosterone and frailty in older men and women.
@en
P2093
P2860
P304
P356
10.1093/AGEING/AFP015
P577
2009-03-09T00:00:00Z